scholarly article | Q13442814 |
P50 | author | Florian Kern | Q48662601 |
Alejandra Pera | Q57106242 | ||
Kevin Davies | Q60665500 | ||
P2093 | author name string | George Morrow | |
Iain Broadley | |||
P2860 | cites work | Functional properties of CD4+ CD28- T cells in the aging immune system | Q77162637 |
High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
Functional subsets of CD4 T cells in rheumatoid synovitis | Q77742322 | ||
Expansion of peripheral CD8+ T cells in patients with coronary artery disease: relation to cytomegalovirus infection | Q79137043 | ||
CD56-expressing T cells that have features of senescence are expanded in rheumatoid arthritis | Q79461195 | ||
Analyses of immunosenescent markers in patients with autoimmune disease | Q79817311 | ||
Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome | Q82956096 | ||
Association of anticytomegalovirus seropositivity with more severe joint destruction and more frequent joint surgery in rheumatoid arthritis | Q83064863 | ||
Baseline numbers of circulating CD28-negative T cells may predict clinical response to abatacept in patients with rheumatoid arthritis | Q84637125 | ||
Effect of the Kv1.3 voltage-gated potassium channel blocker PAP-1 on the initiation and progress of atherosclerosis in a rat model | Q87126188 | ||
Cytomegalovirus infection causes an increase of arterial blood pressure | Q21131578 | ||
Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes | Q24792319 | ||
Molecular and cellular insights into T cell exhaustion | Q26800047 | ||
Human cytomegalovirus and autoimmune disease | Q26850549 | ||
Human memory T cells: generation, compartmentalization and homeostasis | Q26851748 | ||
The story of CD4+ CD28- T cells revisited: solved or still ongoing? | Q28082856 | ||
Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 | ||
Acyclovir Therapy Reduces the CD4+ T Cell Response against the Immunodominant pp65 Protein from Cytomegalovirus in Immune Competent Individuals | Q28546851 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
Role of T-cells in myocardial infarction | Q30315902 | ||
Peripheral and site-specific CD4(+) CD28(null) T cells from rheumatoid arthritis patients show distinct characteristics | Q33782717 | ||
Cardiovascular morbidity and mortality in rheumatoid arthritis | Q33806651 | ||
Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States | Q33838430 | ||
Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study | Q33880835 | ||
Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment | Q33943374 | ||
Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells | Q34221820 | ||
Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies | Q34511615 | ||
Effector and memory T-cell differentiation: implications for vaccine development | Q34632071 | ||
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
The HCMV chemokine receptor US28 is a potential target in vascular disease | Q35010690 | ||
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients | Q35025444 | ||
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions | Q35121150 | ||
Peripheral CD4CD8 double positive T cells with a distinct helper cytokine profile are increased in rheumatoid arthritis | Q35131197 | ||
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis | Q35748061 | ||
Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. | Q36126324 | ||
Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women | Q36154044 | ||
Memory T cell homeostasis and senescence during aging. | Q36228528 | ||
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients | Q47438401 | ||
Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity | Q47598912 | ||
Memory CD4 T cells emerge from effector T-cell progenitors | Q48887186 | ||
CD4+ CD28(null) cells are an independent predictor of mortality in patients with heart failure. | Q48970700 | ||
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. | Q50976939 | ||
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
Cytomegalovirus infection is associated with increased mortality in the older population. | Q51207227 | ||
The precursors of memory: models and controversies. | Q51891099 | ||
CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. | Q51970074 | ||
Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. | Q53095337 | ||
CD4+CD28- T cell expansion in granulomatosis with polyangiitis (Wegener's) is driven by latent cytomegalovirus infection and is associated with an increased risk of infection and mortality. | Q54381201 | ||
Killer Cell Activating Receptors Function as Costimulatory Molecules on CD4+CD28null T Cells Clonally Expanded in Rheumatoid Arthritis | Q56607491 | ||
Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes | Q57192476 | ||
Activating NK-cell receptors co-stimulate CD4+CD28−T cells in patients with rheumatoid arthritis | Q57226743 | ||
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus | Q58230169 | ||
Modulation of CD4 + CD28 null T Lymphocytes by Tumor Necrosis Factor-α Blockade in Patients With Unstable Angina | Q58230246 | ||
Perturbation of the T-Cell Repertoire in Patients With Unstable Angina | Q58230319 | ||
Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis | Q61711491 | ||
Demonstration of cytomegalovirus (CMV) DNA and anti-CMV response in the synovial membrane and serum of patients with rheumatoid arthritis | Q67851543 | ||
Cytomegalovirus genomes demonstrated by polymerase chain reaction in synovial fluid from rheumatoid arthritis patients | Q67856997 | ||
Characterization of CD4(+) CTLs ex vivo | Q74145676 | ||
Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis | Q75190389 | ||
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects | Q36402863 | ||
The repertoire of CD4+ CD28- T cells in rheumatoid arthritis | Q36437991 | ||
The "silent" global burden of congenital cytomegalovirus | Q36558293 | ||
Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection | Q36559592 | ||
CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study | Q36665428 | ||
Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
T-helper type 1 bias in healthy people is associated with cytomegalovirus serology and atherosclerosis: the Multi-Ethnic Study of Atherosclerosis | Q36974273 | ||
Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes | Q37070704 | ||
Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. | Q37209892 | ||
Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III | Q37251214 | ||
Phenotype and function of human T lymphocyte subsets: consensus and issues | Q37266382 | ||
CD4+ CD28 null T cells in coronary artery disease: when helpers become killers | Q37279626 | ||
Role of inflammation in atherosclerosis associated with rheumatoid arthritis | Q37300182 | ||
CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity | Q37354502 | ||
Effector and memory CD4+ and CD8+ T cells in the chronic infection process. | Q37367660 | ||
Immune response profiling in early rheumatoid arthritis: discovery of a novel interaction of treatment response with viral immunity. | Q37689761 | ||
Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 | ||
Heat-shock protein 60-reactive CD4+CD28null T cells in patients with acute coronary syndromes. | Q37867641 | ||
Novel risk factors for cardiovascular disease in rheumatoid arthritis | Q38098935 | ||
The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases | Q38550407 | ||
Increased numbers and functional activity of CD56⁺ T cells in healthy cytomegalovirus positive subjects | Q39033893 | ||
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events | Q40166868 | ||
Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction | Q40278985 | ||
Cytomegalovirus-Infected Primary Endothelial Cells Trigger NKG2C+ Natural Killer Cells. | Q40698451 | ||
Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence | Q40951277 | ||
CD56+ T cells are increased in kidney transplant patients following cytomegalovirus infection | Q41187566 | ||
Expansion of unusual CD4+ T cells in severe rheumatoid arthritis | Q41496871 | ||
Deficiency of fibroblast activation protein alpha ameliorates cartilage destruction in inflammatory destructive arthritis | Q41561823 | ||
Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells | Q42050049 | ||
Cytomegalovirus-induced effector T cells cause endothelial cell damage. | Q42120717 | ||
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes | Q42628689 | ||
Novel anti-inflammatory effect of statins: reduction of CD4+CD28null T lymphocyte frequency in patients with unstable angina. | Q42833030 | ||
Autoimmunity induced by human cytomegalovirus in patients with systemic lupus erythematosus | Q43218530 | ||
Has cytomegalovirus infection any role in the development of atherosclerosis? | Q43792385 | ||
Clonal expansions in selected TCR BV families of rheumatoid arthritis patients are reduced by treatment with the TNFα inhibitors etanercept and infliximab | Q44001527 | ||
Replication of human cytomegalovirus in endothelial cells | Q44766098 | ||
Cytomegalovirus and immunological aging: the real driver of HIV and heart disease? | Q44937735 | ||
Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. | Q44987477 | ||
Asymptomatic cytomegalovirus infection is associated with increased risk of new-onset diabetes mellitus and impaired insulin release after renal transplantation | Q45037412 | ||
Targeting CD4+CD28- T cells by blocking CD28 co-stimulation | Q45389800 | ||
Neopterin, CD4+CD28- lymphocytes and the extent and severity of coronary artery disease | Q46509810 | ||
Characterization of CD4+CD28null T cells in patients with coronary artery disease and individuals with risk factors for atherosclerosis | Q46612705 | ||
P921 | main subject | inflammation | Q101991 |
rheumatoid arthritis | Q187255 | ||
cytotoxicity | Q246181 | ||
P304 | page(s) | 195 | |
P577 | publication date | 2017-03-02 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Expansions of Cytotoxic CD4+CD28- T Cells Drive Excess Cardiovascular Mortality in Rheumatoid Arthritis and Other Chronic Inflammatory Conditions and Are Triggered by CMV Infection | |
P478 | volume | 8 |
Q90446908 | Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression |
Q59355345 | Altered CD4 T cell immunity in nurses occupationally exposed to viral pathogens |
Q64054989 | CD28 CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection |
Q58796708 | CD28 pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death |
Q55459013 | CMV immune evasion and manipulation of the immune system with aging. |
Q41991727 | Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects |
Q64102310 | Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis |
Q40128250 | Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells. |
Q90050594 | NK Cells Contribute to the Immune Risk Profile in Kidney Transplant Candidates |
Q64272869 | Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing |
Q50234923 | Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis |
Q45804014 | The Role of High-Mobility Group Box-1 and Its Crosstalk with Microbiome in Rheumatoid Arthritis. |
Search more.